☰

Dipali A. Nimbalkar, Ph.D. - Publications

Affiliations: 
2004 University of Iowa, Iowa City, IA 
Area:
Pharmacology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Nimbalkar D, Quelle FW. Phosphoinositide 3-kinase signaling overrides a G2 phase arrest checkpoint and promotes aberrant cell cycling and death of hematopoietic cells after DNA damage. Cell Cycle (Georgetown, Tex.). 7: 2877-85. PMID 18769155 DOI: 10.4161/Cc.7.18.6675  0.624
2007 Ray D, Terao Y, Nimbalkar D, Hirai H, Osmundson EC, Zou X, Franks R, Christov K, Kiyokawa H. Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice. Cancer Research. 67: 6605-11. PMID 17638870 DOI: 10.1158/0008-5472.Can-06-4815  0.411
2004 Henry MK, Nimbalkar D, Hohl RJ, Quelle FW. Cytokine-induced phosphoinositide 3-kinase activity promotes Cdk2 activation in factor-dependent hematopoietic cells. Experimental Cell Research. 299: 257-66. PMID 15302592 DOI: 10.1016/J.Yexcr.2004.06.003  0.65
2003 Friedman AD, Nimbalkar D, Quelle FW. Erythropoietin receptors associate with a ubiquitin ligase, p33RUL, and require its activity for erythropoietin-induced proliferation. The Journal of Biological Chemistry. 278: 26851-61. PMID 12746455 DOI: 10.1074/Jbc.M210039200  0.595
2003 Nimbalkar D, Henry MK, Quelle FW. Cytokine activation of phosphoinositide 3-kinase sensitizes hematopoietic cells to cisplatin-induced death. Cancer Research. 63: 1034-9. PMID 12615719  0.674
Show low-probability matches.